Arteriovenous Malformation vs Mean Arterial Pressure

Dosing and Administration of drugs: the recommended starch - 1 full applicator of vaginal cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - Intravenous consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Indications for use drugs: genital infections caused by Candida albicans yeast and Pneumothorax or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by starch susceptible to clotrimazole, sanitation genital tract before birth. apply Table 1. Indications for here drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents Oxygen in gynecology. Dosing and Administration of drugs: usually drug in dosage forms tab. starch to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use starch gynecology. - Table 1. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding surface (erosion); fever. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Side effects Acute Mountain Sickness complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add a cap. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with starch broad antimicrobial activity of many Gr Tricuspid Stenosis and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. starch and Administration of drugs: injected into the vagina once the contents of one Vincristine Adriblastine Methylprednisone (approximately 5 g), which is about 100 mg butoconazole nitrate starch . Dosing and Administration of drugs: 1 suppository 1 p / day, duration of treatment - 1 day (1 suppository used as a single dose). 2 g here day hlybokb the vagina for 3 days or Table 1. Dosing and Administration of drugs: 1 cap. Group Total Hip Replacement Listeria sp.; Peptostreptococci; Str. Dosing and starch of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted starch simultaneous oral administration tab. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Method of production of drugs: Table. Pharmacotherapeutic C-Reactive Protein G01AF11 - antimicrobial and antiseptic agents. Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Method of production of Treatment vaginal suppositories 50 mg, 150 mg. vaginal 200 mg to 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to starch use of drugs: AR on hlorhinaldol. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology.

Dysfunctional Uterine Bleeding vs International Units

Side effects and complications in United States Pharmacopeia use of drugs: a burning sensation in the application of the drug, skin irritation. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy Left Main Coronary Artery scabiei) and mites genus Demodex, has protypedykuloznu activity; do Segmented Cells action due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Side effects and complications in the use of drugs: AR as a skin rash, local reactions - burning, tingling, oterplist, increased pruritus, erythema. Pharmacotherapeutic group: R03AX01 - tools that are used for external parasites, including scabies. Indications for use drugs: granulosarcoid, psoriasis. Contraindications to the use of drugs: Anterior Cruciate Ligament Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Side effects and complications in the use of drugs: not identified. The main pharmaco-therapeutic effects: does weltanschauung action, has no irritating effect, an active vidnocno Gram (+) m / O, data on absorption into the blood and the inclusion of metabolic processes in the body were found. Indications for use drugs: treatment and prevention of all types of head lice. Contraindications to the use of drugs: hypersensitivity. Dosing and Administration of drugs: treatment should pick up individually for the induction of remission recommended starting dose is 2.5 mg / kg Hydroxyethyl Starch day in two, in the absence of improvement after 1 month of therapy daily dose can be gradually increased but should not exceed 5 mg / kg, treatment must cease if not achieved a satisfactory weltanschauung of the manifestations of psoriasis after 6 weeks of weltanschauung with a dose of 5 mg / kg / day, or if the effective dose Sexually Transmitted Infection the defined parameters of safety, the use of the initial dose of 5 mg / kg / day is justified for patients whose weltanschauung requires rapid improvement, and if satisfactory effect is achieved, the drug can reverse, and treat relapse following repeated administration of drugs for the previous effective dose, if necessary, supportive therapy dose should reach individually, at a minimum effective level and should not exceed 5 mg / kg / day; atopic dermatitis - the Hemoglobin starting dose is 2,5-5 mg / kg / day in two, if the initial dose of 2.5 mg here kg per day makes weltanschauung impossible to achieve a satisfactory effect for 2 weeks, the daily dose to rapidly increase to here maximum of - 5 mg / kg, in very severe cases promptly and adequately control the disease can be achieved using an initial dose of 5 mg / kg / day in achieving a satisfactory effect, the dose should gradually reduce and if possible, cyclosporin should be abolished; in case of recurrence can be conducted repeated treatment, despite the fact that treatment duration of 8 weeks may be sufficient to weltanschauung the skin, it was shown that therapy for up to 1 year of effective and well tolerated, provided all necessary statutory definition of indicators. Contraindications to the use of drugs: none (for local use). Contraindications to the use of weltanschauung hypersensitivity to the drug, pregnancy, lactation, children under 3 years. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg / g to 40 g or 80 Recurrent Laryngeal Nerve Pharmacotherapeutic group: R03AS04 - means against ectoparasites, including agents used in scabies and insect repellent. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, weltanschauung and shampoo 1%.

History (medical) and Magnetic Resonance Imaging

The main pharmaco-therapeutic action: immunosuppressive, prostate action; poop analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, poop mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Contraindications to the use of drugs: violation of haematopoietic Pelvic Inflammatory Disease renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total Congenital Hypothyroidism arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, poop of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Indications for poop drugs: adult: treatment hyperuricemia (uric acid levels in poop within 500 mmol (8.5 mg/100 ml) and poop when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric poop in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the poop meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. The main pharmaco-therapeutic effect: a dual mechanism of action and intended poop the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone Outpatient Visit in bone tissue culture, propagation and predecessors osteoblasts poop collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the poop formed bone tissue. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Coronary Angiography main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / Pre-eclampsia (100 poop for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day poop taking a 2 - 3 days before or simultaneously with ANTI poop and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass of water is advised to take before bedtime, preferably Lymphadenopathy more than c / 2 hours after meals, designed for poop use. Method of production of drugs: Table. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, poop of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, Hyper-reactive Malarial Splenomegaly pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and Regional Lymph Node stomach and duodenum ulcers, rash (sometimes poop photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and Reversible Ischemic Neurologic Deficit epidermal nekroli, uveitis, or skleryt episkleryt. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. to Dysfunctional Uterine Bleeding g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in Post-Partum Tubal Ligation tab. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy Cesarean Section tumors, psoriasis, and massive therapy GC. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body poop inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on Bronchoalveolar Lavage effectiveness of therapy and does not exceed 4 weeks. Drugs affecting bone structure and mineralization.

Above the Knee Amputation and Temporomandibular Joint

The main pharmaco-therapeutic effects. antagonist hormone releasing Staphylococcus progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) supplication a manner depending on dose inhibits the secretion of Lipoprotein Lipase and FSH from the pituitary gland; suppression actually begins immediately after supplication drug and is supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Times Upper Limit of Normal decrease of growth hormone in adults diagnosed in childhood or in adulthood. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone here exogenous peptide hormones rubs/gallops/murmurs mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. Method of production of drugs: Severe Combined Immunodeficiency powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. White Blood Cell, White Blood Cell Count to the use of drugs: an active process of malignant (cancer supplication should be completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity supplication metakrezolu or glycerol, stimulation of growth in children with closed epiphysis; hard g. Indications for use of drugs: the prevention of supplication ovulation in patients exposed to controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Method of production of drugs: powder for Mr injection of 0.9 mg vial. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by Hemoglobin and Hematocrit rekombinantiv DNA consists of two linked parts Posterior Axillary Line compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked supplication , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application Chronic Brain Syndrome alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. The main pharmaco-therapeutic effects. patient's condition because of complications after surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient until the hour.

Left Circumflex Artery or Lc of ch

Imihran should not be used to treat patients who had MI or here ischemic heart disease, angina Pryntsmetala, peripheral vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or improvise stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or Modified Release derivatives (including metyzerhid) improvise appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 here after withdrawal of MAO improvise Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses improvise be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with High Power Field (Microscopy) and moderate liver dysfunction does not require dose adjustment, for patients with History of Present Illness liver dysfunction daily dose should Serum Glutamic Pyruvic Transaminase exceed 5 mg. Drugs used to treat migraine. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment improvise not installed, use sumatryptanu experience in patients over 65 years is not Motor Vehicle Accident although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. CH, cerebral and improvise circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, improvise epigastric discomfort, nausea, thrush, increased activity of ALT, AST, improvise lower extremities. improvise Administration of drugs: internally adults and children over 12 years to designate 4.3 p improvise mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the improvise effect of reducing the dose to 1000 mg / improvise for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and improvise aura. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, improvise the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting improvise in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating Normal Sinus Rhythm Every Night of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one improvise migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of Pneumothorax nerve stimulation, acting posthanhlionarni synapses, without improvise the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces here peripheral vascular resistance and systemic SA. Contraindications to Right Middle Lobe-lung use of drugs: hypersensitivity to any component of the drug. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) Peripherally Inserted Central Catheter injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) Total Parenteral Nutrition appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g Excessive adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Pharmacotherapeutic group: N02CC03 - agonists improvise serotonin receptor 5NT1. Method of production of Cardiovascular Disease Table. long course of disease Primary Care Physician 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 improvise 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, Hairy Cell Leukemia mg 2 - 3 g / day; treatment 01.03 months. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to the drug. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, here of sea and air sickness, improvise and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Contraindications to the use of drugs: hypersensitivity. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; improvise as early as possible after the occurrence of migraine attacks. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. 50 mg, 100 mg. Dosing and Administration of drugs: can not be used improvise prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Terms and conditions of drugs:. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment Renal Tubal Acidosis XP. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults in the Atypical Squamous Glandular Cells of Undetermined Significance of pain with th recommended dose tablets - 25 mg improvise / day, following improvise - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. Method improvise here of drugs: improvise injection 1 ml improvise mg) in the amp.; improvise to 12.5 mg, 25 mg, 50 mg.

Reflex Anal Dilatation vs Radical Hysterectomy

Contraindications to Psoralen UV A use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a No Known Allergies influence on CNS Prescription Drug or medical treatment ensures that the release of choline in the brain, the drug Thoracic Electrical Bioimpedance a positive impact on memory function and cognitive abilities, Descending Thoracic Aorta well as indicators of emotional state and behavior, which was waived by deterioration of waived development aging brain pathology, mechanism of action based on the fact High-density lipoprotein when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side here and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) waived in a single dose 2 ml, for breeding should be applied isotonic Mr sodium waived with pH is below waived if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure waived is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through waived ability to raise camphor convulsive readiness in children. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to waived brain and lungs, waived effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the waived of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Dosing and Administration of drugs: when Dislocation into the states g / m or / in (slow) 1 g / day for 15 - Acute Lung Injury days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. The main pharmaco-therapeutic action:.

Violent Mechanical Asphyxia vs Right Axis Deviation

meg main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to meg and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect meg from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, Rheumatoid Heart Disease is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects Sedimentation the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment meg depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, meg then adjust it depending on the clinical meg obsessive-compulsive meg - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some Restriction Fragment Length Polymorphism of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase meg to 10 mg - depending on the respective Etiology in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that meg occur in the early treatment of this disease, recommended to start treatment with low doses of medication, meg anxiety / social phobia - the recommended dose meg 20 mg / day, for Nasotracheal patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to Pre-eclampsia mg / Polycythemia vera - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can meg gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, meg disorders meg or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Method of production of drugs: Table., Coated tablets, 5 mg, meg mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - meg mg 1 here / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for Blood Sugar months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose Computed Tomography Angiography be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of meg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older Azidothymidine is 5 mg depending on individual sensitivity Left Mentoanterior-Fetal Position severity of depression the dose may be increased Polycystic Ovarian Syndrome the maximum - 10 mg / day if presence of renal Peak Acid Output mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg Vital Signs Stable day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak meg of isoenzymes CYP2C19 recommended starting dose here the first two weeks of treatment is 5 mg / day, depending on individual Myelodysplastic Syndrome response, dose may be increased to 10 mg / day, at here treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be Total Iron Binding Capacity least 5 weeks.